Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease.

scientific article published on November 1993

Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/0741-8329(93)90063-T
P698PubMed publication ID8123198

P50authorErik EliassonQ42530438
Emanuele AlbanoQ57720366
P2093author name stringM Ingelman-Sundberg
H Yin
I Johansson
P Clot
Y Terelius
P433issue6
P304page(s)447-452
P577publication date1993-11-01
P1433published inAlcoholQ15724430
P1476titleEthanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease
P478volume10

Reverse relations

cites work (P2860)
Q573028083 The pharmacology of the cytochrome P450 enzyme system
Q46048455A haplotype analysis of CYP2E1 polymorphisms in relation to alcoholic phenotypes in Mexican Americans
Q40920371A soluble NH(2)-terminally truncated catalytically active form of rat cytochrome P450 2E1 targeted to liver mitochondria(1).
Q44233478Alcoholic liver injury and apoptosis--synopsis of the symposium held at ESBRA 2001: 8th Congress of the European Society for Biomedical Research on Alcoholism, Paris, September 16, 2001.
Q51523474An investigation of cytochrome p450 (CYP) and glutathione S-transferase (GST) isoenzyme protein expression and related interactions with phototherapy in patients with psoriasis vulgaris.
Q34116666Aquaporin-4 knockout enhances astrocyte toxicity induced by 1-methyl-4-phenylpyridinium ion and lipopolysaccharide via increasing the expression of cytochrome P4502E1.
Q43775833CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people
Q38418677CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls
Q64898654CYP2E1 and CYP3A1/2 gene expression is not associated with the ursodeoxycholate effect on ethanol-induced lipoperoxidation.
Q73635116CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan
Q46886032Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid
Q38008699Choline deprivation: an overview of the major hepatic metabolic response pathways
Q44341681Cinnamic compound metabolism in human skin and the role metabolism may play in determining relative sensitisation potency
Q46067848Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors
Q47182200Cytochrome P4502E1 genotypes, alcoholism, and alcoholic cirrhosis in Han Chinese and Atayal Natives of Taiwan
Q57550414Determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma by gas chromatography–mass spectrometry
Q77619522Dietary carbohydrate intake plays an important role in preventing alcoholic fatty liver in the rat
Q47965928Different dosages of acetylsalicylic acid lead to adverse modifications of the reaction of rat pancreas to ethanol
Q77910649Differential induction of rat hepatic microsomal epoxide hydrolase and rGSTA2 by diazines: the role of cytochrome P450 2E1-mediated metabolic activation
Q53622513Effect of chronic dietary ethanol in the promotion of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats.
Q47986521Effect of ethanol administration on the level of dolichol in rat liver microsomes and Golgi apparatus
Q34315186Effects of SNPs (CYP1B1*2 G355T, CYP1B1*3 C4326G, and CYP2E1*5 G-1293C), smoking, and drinking on susceptibility to laryngeal cancer among Han Chinese
Q44361860Enhancing risk of ethanol on MeIQx-induced rat hepatocarcinogenesis is accompanied with increased levels of cellular proliferation and oxidative stress
Q73447652Ethanol downregulates transcription of the PAI-1 gene in cultured human endothelial cells
Q43686104Ethanol enhances the formation of endogenously and exogenously derived adducts in rat hepatic DNA.
Q38687958Ethanol metabolism, toxicity and genetic polymorphism
Q47861259Ethanol transcriptionally upregulates t-PA and u-PA gene expression in cultured human endothelial cells
Q32117371Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells
Q43707092Examination of a CYP2E1 repeat polymorphism in a monkey model of alcohol abuse
Q48558516Expression of constitutive and inducible cytochrome P450 2E1 in rat brain
Q43680878Gender difference in enzymes related with alcohol consumption in hamster, an avid consumer of alcohol
Q38824701Gene copy number variation analysis reveals dosage-insensitive expression of CYP2E1.
Q32117706Genetic determinants of alcohol addiction and metabolism: a survey in Italy
Q47643728Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in a Chinese Tibetan population
Q37698409Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity
Q43735186Genetic polymorphism of cytochrome P450 2E1 in the Turkish population
Q71497772Genetic polymorphism of human cytochrome P450 2E1
Q33918450Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis.
Q43643581Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics
Q40648076Glucose inhibition of the induction of CYP2E1 mRNA expression by ethanol in FGC-4 cells
Q35327402Gut microbiome and nonalcoholic fatty liver diseases
Q74027130Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Q74184908How does the body deal with energy from alcohol?
Q40832491Identification and characterization of a mitochondrial targeting signal in rat cytochrome P450 2E1 (CYP2E1).
Q43616528Identification of a 251-bp fragment of the PAI-1 gene promoter that mediates the ethanol-induced suppression of PAI-1 expression
Q72294030Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue
Q91816495In Vivo Hepatoprotective Effects of a Peptide Fraction from Krill Protein Hydrolysates against Alcohol-Induced Oxidative Damage
Q44637720In vivo monitoring of hepatic oxygenation changes in chronically ethanol‐treated rats by functional magnetic resonance imaging
Q40909505Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytoxicity
Q51587174Induction mechanisms of cytochrome P450 2E1 in liver: Interplay between ethanol treatment and starvation
Q36372912Induction of CYP2E1 in non-alcoholic fatty liver diseases
Q44094041Influence of chronic ethanol consumption on toxic effects of 1,2-dichloroethane: glycolipoprotein retention and impairment of dolichol concentration in rat liver microsomes and Golgi apparatus
Q41249900Influence of ethanol on in vitro growth of human mammary carcinoma cell line MCF-7.
Q51446446Influence of urethane and ketamine on rat hepatic cytochrome P450 in vivo.
Q47722066Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers
Q42550847Inhibition of cytochrome P450 2E1 expression by 2-(allylthio)pyrazine, a potential chemoprotective agent: hepatoprotective effects
Q74012586Kupffer cell inactivation alleviates ethanol-induced steatosis and CYP2E1 induction but not inflammatory responses in rat liver
Q28382981Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model
Q77409352Liver nuclear ethanol metabolizing systems (NEMS) producing acetaldehyde and 1-hydroxyethyl free radicals
Q43553305Lymphocyte cytochrome P450-CYP2E1 expression in human IDDM subjects
Q72282193Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors
Q57371875Molecular Basis for the Transport of Cytochrome P450 2E1 to the Plasma Membrane
Q41046037Molecular and genetic aspects of ethanol in human diet: a nutrient or a toxicant?
Q36832562NOX in liver fibrosis
Q40335692Overexpression of CYP2E1 in mitochondria sensitizes HepG2 cells to the toxicity caused by depletion of glutathione
Q73208604Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium
Q44252918Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population
Q43967442Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis
Q73332856Polymorphism in the cytochrome P450 2E1 gene and the risk of alcoholic liver disease
Q36376313Polymorphism of Alcohol Metabolizing Gene ADH3 Predisposes to Development of Alcoholic Pancreatitis in North Indian Population
Q47899895Role of cytokines in ethanol-induced cytotoxicity in vitro in Hep G2 cells
Q52843675Roles of CYP2e1 in 1,2-dichloroethane-induced liver damage in mice.
Q34555838Roles of cytochrome P4502E1 gene polymorphisms and the risks of alcoholic liver disease: a meta-analysis
Q37517351RsaI but not DraI polymorphism in CYP2E1 gene increases the risk of gastrointestinal cancer in Malaysians: a case-control study
Q34410274RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma
Q40799272Signaling for ethanol-induced apoptosis and repair in vitro
Q43593962Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis
Q40719876Synergetic signaling for apoptosis in vitro by ethanol and acetaminophen
Q28481380Systematic functional characterization of cytochrome P450 2E1 promoter variants in the Chinese Han population
Q44413777The ADH3*2 and CYP2E1 c2 alleles increase the risk of alcoholism in Mexican American men
Q33726099The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.
Q31386626The effects of the ALDH2*1/2, CYP2E1 C1/C2 and C/D genotypes on blood ethanol elimination
Q37835918The impact of CYP2E1 genetic variability on risk assessment of VOC mixtures
Q41401684The metabolism of psychoactive drugs: a review of enzymatic biotransformation and inhibition
Q40418751The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies

Search more.